132 related articles for article (PubMed ID: 9100303)
1. Molecular and cellular mechanisms of early mammalian development: an overview of NIEHS/EPA Developmental Toxicity Workshops.
Bishop JB; Kimmel CA
Reprod Toxicol; 1997; 11(2-3):285-91. PubMed ID: 9100303
[No Abstract] [Full Text] [Related]
2. New approaches for assessing the etiology and risks of developmental abnormalities from chemical exposure.
Goldman LR
Reprod Toxicol; 1997; 11(2-3):443-51. PubMed ID: 9100320
[TBL] [Abstract][Full Text] [Related]
3. The Future of the National Children's Study.
Duncan GJ; McCormick MC; Citro CF
JAMA Pediatr; 2015 Jun; 169(6):517-8. PubMed ID: 25844727
[No Abstract] [Full Text] [Related]
4. In the Aftermath of the National Children's Study.
Perrin JM; Batlivala SP; Cheng TL
JAMA Pediatr; 2015 Jun; 169(6):519-20. PubMed ID: 25844511
[No Abstract] [Full Text] [Related]
5. NIEHS/EPA Workshops. Growth and differentiation factors.
Sadler TW; Rogers M; Slavkin H; Lauder J; Maness P; Linney E; Sulik K; Mirkes P
Reprod Toxicol; 1997; 11(2-3):331-7. PubMed ID: 9100308
[TBL] [Abstract][Full Text] [Related]
6. [Etiology of developmental defects].
Rokicki W; Rokicka A; Latoszkiewicz K
Pol Tyg Lek; 1988 Sep; 43(39):1266-9. PubMed ID: 3072546
[No Abstract] [Full Text] [Related]
7. EPA priorities for biologic markers research in environmental health.
Fowle JR; Sexton K
Environ Health Perspect; 1992 Nov; 98():235-41. PubMed ID: 1486855
[TBL] [Abstract][Full Text] [Related]
8. Researchers hunt for elusive environmental causes of leukemia.
Reynolds T
J Natl Cancer Inst; 1998 Jan; 90(2):90-2. PubMed ID: 9450564
[No Abstract] [Full Text] [Related]
9. Lessons learned for the National Children's Study from the National Institute of Environmental Health Sciences/U.S. Environmental Protection Agency Centers for Children's Environmental Health and Disease Prevention Research.
Kimmel CA; Collman GW; Fields N; Eskenazi B
Environ Health Perspect; 2005 Oct; 113(10):1414-8. PubMed ID: 16203257
[TBL] [Abstract][Full Text] [Related]
10. Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk.
Kavlock R; Dix D
J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):197-217. PubMed ID: 20574897
[TBL] [Abstract][Full Text] [Related]
11. Children's health study closer to launch: lack of funding could cause delays.
Kuehn BM
JAMA; 2005 Nov; 294(17):2154. PubMed ID: 16264151
[No Abstract] [Full Text] [Related]
12. Developmental toxicology: methods and protocols. Volume overview: introduction.
Harris C
Methods Mol Biol; 2012; 889():1-5. PubMed ID: 22669655
[TBL] [Abstract][Full Text] [Related]
13. Approaches and considerations for the assessment of immunotoxicity for environmental chemicals: a workshop summary.
Boverhof DR; Ladics G; Luebke B; Botham J; Corsini E; Evans E; Germolec D; Holsapple M; Loveless SE; Lu H; van der Laan JW; White KL; Yang Y
Regul Toxicol Pharmacol; 2014 Feb; 68(1):96-107. PubMed ID: 24280359
[TBL] [Abstract][Full Text] [Related]
14. Uncertainties for endocrine disrupters: our view on progress.
Daston GP; Cook JC; Kavlock RJ
Toxicol Sci; 2003 Aug; 74(2):245-52. PubMed ID: 12730617
[TBL] [Abstract][Full Text] [Related]
15. Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity: summary and implications.
Francis EZ; Kimmel CA; Rees DC
Neurotoxicol Teratol; 1990; 12(3):285-92. PubMed ID: 2196427
[TBL] [Abstract][Full Text] [Related]
16. Assessment of reproductive disorders and birth defects in communities near hazardous chemical sites. I. Birth defects and developmental disorders.
Savitz DA; Bornschein RL; Amler RW; Bove FI; Edmonds LD; Hanson JW; Kaye WE; Khoury M; Kiely M; Lemasters GK; Sever LE; Shepard TH; Spengler RF; Steinberg KK; Yeargin-Allsopp M
Reprod Toxicol; 1997; 11(2-3):223-30. PubMed ID: 9100297
[TBL] [Abstract][Full Text] [Related]
17. Assessment of reproductive disorders and birth defects in communities near hazardous chemical sites: introduction.
Amler RW
Reprod Toxicol; 1997; 11(2-3):221-2. PubMed ID: 9100296
[No Abstract] [Full Text] [Related]
18. Developmental toxicity risk assessment: consensus building, hypothesis formulation, and focused research.
Kimmel CA
Drug Metab Rev; 1996; 28(1-2):85-103. PubMed ID: 8744591
[TBL] [Abstract][Full Text] [Related]
19. Gene-environment interactions in rare diseases that include common birth defects.
Graham JM; Shaw GM
Birth Defects Res A Clin Mol Teratol; 2005 Nov; 73(11):865-7. PubMed ID: 16265646
[TBL] [Abstract][Full Text] [Related]
20. [Reproductive/Developmental Abnormalities Induced by Epigenetic Aberrations and Possible Environmental Causes].
Kawai T; Hata K
Nihon Eiseigaku Zasshi; 2016; 71(3):195-199. PubMed ID: 27725422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
